首页> 美国卫生研究院文献>Aging (Albany NY) >Exosomal long non-coding RNA LINC00662 promotes non-small cell lung cancer progression by miR-320d/E2F1 axis
【2h】

Exosomal long non-coding RNA LINC00662 promotes non-small cell lung cancer progression by miR-320d/E2F1 axis

机译:外泌体长的非编码RNA LINC00662通过MIR-320D / E2F1轴促进非小细胞肺癌进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Non-small cell lung cancer (NSCLC) is the most common tumor affecting modern people and is associated with severe morbidity and high mortality. Exosomal long non-coding RNAs as crucial regulators are involved in cancer progression. However, the role of exosomal lncRNA LINC00662 in the development of NSCLC remains unclear. Here, we aimed to explore the impact of exosomal lncRNA LINC00662 on the NSCLC progression and the underlying mechanism. Significantly, we revealed that the expression of lncRNA LINC00662 was elevated in the plasma exosome of NSCLC patients. Exosomal LINC00662 promoted proliferation, invasion, and migration, and inhibited apoptosis and cell cycle arrest of NSCLC cells. Mechanically, LINC00662 was able to serve as a miR-320d sponge in NSCLC cells. MiR-320d could target E2F1 in NSCLC cells. Exosomal LINC00662 contributed to the progression of NSCLC by miR-320d/E2F1 axis in vitro. Remarkably, exosomal LINC00662 enhanced the tumor growth of NSCLC in vivo. Thus, we conclude that exosomal lncRNA LINC00662 promotes NSCLC progression by modulating miR-320d/E2F1 axis. Our finding provides new insights into the mechanism by which exosomal lncRNA LINC00662 contributes to the development of NSCLC. LncRNA LINC00662, miR-320d, and E2F1 may serve as potential targets for NSCLC therapy.
机译:非小细胞肺癌(NSCLC)是影响现代人的最常见的肿瘤,与严重的发病率和高死亡率有关。作为关键稳压剂的外泌体长期非编码RNA参与癌症进展。然而,外泌体LNCRNA LINC00662在NSCLC发育中的作用尚不清楚。在这里,我们旨在探讨外泌体LNCRNA LINC00662对NSCLC进展和潜在机制的影响。值得注意的是,我们揭示了LNCRNA LINC00662的表达在NSCLC患者的血浆外部升高。外泌体LINC00662促进增殖,侵袭和迁移,抑制NSCLC细胞的细胞凋亡和细胞周期骤停。机械地,LINC00662能够用作NSCLC细胞中的miR-320d海绵。 miR-320D可以针对NSCLC细胞中的e2f1。外泌体LINC00662有助于MIR-320D / E2F1轴在体外进行NSCLC的进展。值得注意的是,外泌体LINC00662增强了体内NSCLC的肿瘤生长。因此,我们得出结论,外泌体LNCRNA LINC00662通过调节miR-320D / E2F1轴来促进NSCLC进展。我们的发现提供了新的见解,进入ExoOmal Lncrna Linc00662对NSCLC的发展有助于发展的机制。 LNCRNA LINC00662,MIR-320D和E2F1可用作NSCLC疗法的潜在靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号